glp-1 and inflammation Glucagon-like peptide-1 receptor: mechanisms advances in therapy Anti-Inflammatory Effects of GLP-1R Activation
Description
Some GLP1RAs (liraglutide and semaglutide) have proved to have positive effects on cardiovascular outcomes in T2DM

Kettmann, U., Humbel, B

The effect sizes were modest (about 2 to 3 percent reduction in body measurements), but statistically significant

At the 12 mg dose, 93% of participants achieved at least 5% weight loss

Beginning a genuine trial now positions you to notice effects during the window you care most about

Semaglutide oral drops* are a non-injectable formulation of semaglutide, delivering the same active compound under the tongue instead of via injection